Therapy News and Research

RSS

Biomira files NDA for novel inhibitor of hypoxia-inducible factor-1 alpha

Biomira Inc. has announced that it has submitted an investigational new drug (IND) application to the U.S. Food and Drug Administration for PX-478. PX-478 has been shown in preclinical studies to inhibit hypoxia-inducible factor (HIF)-1 alpha, a protein that controls the transcription of a number of genes whose products are important for tumor growth and survival.

4 Jul 2007

Complementary and alternative therapies for diabetes

People with diabetes are risking their health by not discussing their use of complementary and alternative therapies with the health professionals managing their conventional treatment.

4 Jul 2007

The next era of cancer treatment

Teaching a body's own immune system to seek out and destroy cancerous tumours represents a promising way to fight a disease that kills more than 70,000 Canadians a year.

4 Jul 2007

Study to look at effect of using nicotine patches during pregnancy

1050 pregnant women are being recruited for the most extensive trial of its kind to establish the effect of using nicotine patches during pregnancy.

4 Jul 2007

Complementary therapies in assisted reproduction may diminish the effectiveness of medical treatment for infertility in women

Many women use complementary or alternative therapies (CATs) to resolve fertility problems, even though there is little evidence that they are effective.

4 Jul 2007

Genetic embryo screening found to be a costly mistake for many women

According to a new study older women whose embryos were screened for defects before being implanted in the womb lessened their chance of a successful pregnancy.

4 Jul 2007

Skin rash actually signifies better outcomes for pancreatic and lung cancer patients

The appearance of a rash in cancer patients treated with erlotinib (Tarceva) is strongly associated with longer survival, according to researchers from the drug's developer, OSI Pharmaceuticals, Inc.

3 Jul 2007

Fat kills cancer!

Researchers in Slovakia have been able to derive mesenchymal stem cells from human adipose, or fat, tissue and engineer them into "suicide genes" that seek out and destroy tumors like tiny homing missiles.

3 Jul 2007

Experts warn about dangers of spinal manipulation treatment

Experts are warning that manipulating the upper spine during back treatments could be dangerous.

3 Jul 2007

Food allergy sufferers offered hope of new treatment

In a joint UK and Italian study scientists say they have discovered a possible treatment for people who suffer from food allergies.

3 Jul 2007

Young girls have eggs extracted before chemo to protect fertility

Israeli fertility experts have extracted and frozen eggs from girls as young as five about to undergo chemotherapy and frozen them so they can be used later to start a family.

3 Jul 2007

Yogurt drink helps patients avoid diarrhea caused by antibiotics

According to a new study by British researchers probiotic yogurt drinks containing "good" bacteria help patients avoid the diarrhea caused by antibiotics.

2 Jul 2007

Exercise good for those brain cells

According to Swedish researchers exercise may stimulate the production of new brain cells in the area of the brain that is important to memory and learning.

2 Jul 2007

Young adult smokers are highly motivated to quit

Despite tried and true methods to quit smoking, young adults do not take advantage of these proven smoking cessation treatments that can double their chances of quitting, University of Illinois at Chicago public health researchers report.

29 Jun 2007

Therapeutic value of meditation unproven

There is an enormous amount of interest in using meditation as a form of therapy to cope with a variety of modern-day health problems, especially hypertension, stress and chronic pain, but the majority of evidence that seems to support this notion is anecdotal, or it comes from poor quality studies, say Maria Ospina and Kenneth Bond, researchers at the University of Alberta/Capital Health Evidence-based Practice Center in Edmonton, Canada.

29 Jun 2007